Search PubMedSearch

PubMed · 3204495

Polyether polyurethanes: biostable or not?

Abstract

Certain polyether polyurethanes have been shown to be biostable in long-term implant studies. Others retain good bulk properties, but have been shown to develop cracks on their tissue contacting surfaces. Two cracking mechanisms have been identified, in vivo stress cracking and metal ion oxidation. Stress cracking is the result of an interaction between the in vivo mammalian environment and residual stress (strain) in the implanted polymer. Mild autooxidation can be initiated by stress cracking. More extensive autooxidation can be initiated and propagated by corrosion of metallic device components, especially the corrosion products of cobalt. Both mechanisms are controllable, thus, do not necessarily preclude the use of polyether polyurethanes in implantable devices.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K B Stokes. 1988. Polyether polyurethanes: biostable or not?. https://doi.org/10.1177/088532828800300205

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Value of routine follow-up after infrainguinal arterial reconstruction].

Longterm patency of infrainguinal bypass procedures may be established on the basis of clinical evaluation and ankle pressure measurements. With the aim of assessing whether these parameters could predict grafts at risk for occlusion, we identified 24 patients in whom the bypass had occluded between 3 and 12 months postoperatively, but following at least one follow-up. These patients were compared with a control group consisting of further 24 patients operated on during the same period, but in whom the bypass was patent. Prior to graft occlusion only nine (39%) patients had complained of claudication, and a significant drop in ankle pressure was demonstrated in seven (29%) patients. These figures were significantly higher than the one (4%) patient in the control group who complained of claudication and the other (4%) patient who developed a drop in ankle pressure (p < 0.02 and 0.05, respectively). Graft surveillance based on patients' history and ankle pressure measurements are insufficient parameters for identification of grafts at risk for occlusion. However, the occurrence of claudication and/or a significant drop in ankle pressures are associated with a high incidence of graft thrombosis.

Biocompatible Materials

[Implantation of a Stecker metal prosthesis in malignant stenosis of the gastric stump].

A 55 year old patient 3 years after gastric resection (Billroth II) has got gastric outlet stenosis. Half year ago was established a tumour recidive, that the time of reoperation was inoperable. Under endoscopic and radiological control we have introduced and placed a 19 mm diameter, 4 cm long balloon expandable tantalum stent (Strecker stent). The gastric passage has normalised and after 6 month the patient is symptom free.

Biocompatible Materials